COMPANY PROFILE

Peptilogics

Explore full profile

A biotech company developing a breakthrough technology platform in the antimicrobial segment

Pittsburgh, United StatesFounded 2013Biotech & Life Sciences

Valuation $250–500M Last recorded · 2025

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Peptilogics

Peptilogics is a clinical-stage biotechnology company focused on transforming the discovery and development of novel peptide therapeutics. The company leverages the untapped potential of peptide biology combined with the power of machine learning to scale its drug design approach. Peptilogics aims to usher in the next generation of peptide therapeutics through precision engineering and design. Its lead therapeutic, PLG0206, is a novel, broad-spectrum anti-infective currently under clinical investigation for the treatment of prosthetic joint infection, a condition with significant unmet medical needs. The company primarily serves patients with serious and life-threatening diseases, operating within the biotechnology and pharmaceutical markets. Peptilogics generates revenue through the development and potential commercialization of its peptide-based drugs.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2013
Headquarters: Pittsburgh, United States
Employees: 22
Open positions: None listed
Dealroom signal: 85.6/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Drug Development, Infections and Infectious Diseases, Spinout, Alternative Protein
Technology: Artificial Intelligence, Big Data, Deep Tech, Deep Learning
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Oct 2025	$78M	$312M	AMR Action Fund · Beyond Ventures · Presight Capital · Thiel Bio	↗
GRANTOther financing	Jan 2025	$3.3M	—	CARB-X	↗

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Peptilogics website traffic

Latest recorded traffic for Peptilogics is 4.1K monthly website visits, down 4.7% over the last three months. Peptilogics's team grew 10% over the past year.

Latest monthly visits4.1K 3-month web change-4.7% 1-year team growth+10%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Senior Clinical Trial Manager New Pittsburgh, Pennsylvania, United States, RemotePittsburgh, Pennsylvania, United States, Northern America, Americas · Other · Aug 23, 2026 Chief Financial Officer (CFO) New Pittsburgh, Pennsylvania, United States, RemotePittsburgh, Pennsylvania, United States, Northern America, Americas · C-Level · Aug 9, 2026 Director, Investor Relations & Communications New Pittsburgh, Pennsylvania, United States, RemotePittsburgh, Pennsylvania, United States, Northern America, Americas · Marketing & Communication · Aug 9, 2026 Director, Investor Relations & CommunicationsPittsburgh, PA · Finance · Aug 7, 2026 Chief Financial Officer (CFO)Pittsburgh, PA · C-Level · Aug 7, 2026

5 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PEPepticomAn Artificial Intelligence (AI) company for the discovery of novel molecules in the Pharmaceutical and Agricultural markets	Jerusalem, Israel	Operational	16	$14M	$26M
CHChemifyDigitizing chemistry by developing technology to convert chemical code into molecules and vice versa	Glasgow, United Kingdom	Operational
MTMETiS TherapeuticsAI-driven platform for drug discovery and delivery	Cambridge, United States	Operational
SBSibylla BiotechFacing the complexity of drug discovery with the power of an innovative approach for meeting unmet medical needs	Bresso, Italy	Operational
STScripta TherapeuticsAI-driven drug discovery modulating transcription factor activity	Oxford, United Kingdom	Operational
INInVirtuoLabsModular AI solutions accelerating drug discovery with predictive models and generative simulations	Lugano, Switzerland	Operational
VIVilyaDeveloping a novel class of drugs that precisely target the biology of disease	Seattle, United States	Operational
BIBioSimulyticsIn-silico drug development for API small molecules ⚛️	Dublin, Ireland	Operational